Reported adverse effects of SGLT-2 inhibitors included urinary tract infection (43.8%), small ulcers in lower extremities (10%), cellulitis (10%), AKI (3.6%), and genital fungal infection (1.4%), respectively. Here, SLC5A2 is linked to urinary tract infection.